107 related articles for article (PubMed ID: 1455399)
1. Structure, kinetics, and function of human and rhesus plasma prekallikreins are similar.
Veloso D; Smith JI; Denny S; Cosgriff TM
Thromb Haemost; 1992 Nov; 68(5):526-33. PubMed ID: 1455399
[TBL] [Abstract][Full Text] [Related]
2. Western blot analyses of prekallikrein and its activation products in human plasma.
Veloso D; Colman RW
Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
[TBL] [Abstract][Full Text] [Related]
3. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
Derkx FH; Bouma BN; Schalekamp MA
J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin on the activation of factor XII and the contact system in plasma.
Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
[TBL] [Abstract][Full Text] [Related]
5. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
Veloso D; Silver LD; Hahn S; Colman RW
Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
[TBL] [Abstract][Full Text] [Related]
7. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
8. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
9. Studies on contact activation: effects of surface and inhibitors.
Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
[TBL] [Abstract][Full Text] [Related]
10. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
Imamura T; Dubin A; Moore W; Tanaka R; Travis J
Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
[TBL] [Abstract][Full Text] [Related]
11. Rhesus differential susceptibility to endotoxin is not associated with activation of plasma prekallikrein.
Veloso D; Smith JI; Cosgriff TM
Immunopharmacology; 1999 Sep; 43(2-3):265-71. PubMed ID: 10596862
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the rate of contact activation in human plasma.
Brunnée T; Coy G; Reddigari SR; Silverberg M
Agents Actions Suppl; 1992; 38 ( Pt 2)():231-6. PubMed ID: 1462830
[TBL] [Abstract][Full Text] [Related]
13. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
Roeise O; Bouma BN; Stadaas JO; Aasen AO
Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of a variant prekallikrein (PK Zürich).
Wuillemin WA; Furlan M; von Felten A; Lämmle B
Thromb Haemost; 1993 Sep; 70(3):427-32. PubMed ID: 8259543
[TBL] [Abstract][Full Text] [Related]
15. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
Page JD; Colman RW
J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
[TBL] [Abstract][Full Text] [Related]
16. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
Olson ST; Francis AM; Sheffer R; Choay J
Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
[TBL] [Abstract][Full Text] [Related]
17. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
18. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
Page JD; You JL; Harris RB; Colman RW
Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
[TBL] [Abstract][Full Text] [Related]
19. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
Gallimore MJ; Friberger P
Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
[No Abstract] [Full Text] [Related]
20. Plasma kallikrein activation and inhibition during typhoid fever.
Colman RW; Edelman R; Scott CF; Gilman RH
J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
